Pharmaceutical Industry Labor Management Association (Pilma)
An association comprised of pharmaceutical companies and labor unions
Based in VA
🤖
AI Overview
With $1.0M in lobbying spend across 32 quarterly filings, Pharmaceutical Industry Labor Management Association (Pilma) is a significant lobbying presence. Their lobbying covers 2 issue areas. Active from 2018 to 2025.
$1.0M
Total Spend
8
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $120K |
| 2019 | $120K |
| 2020 | $120K |
| 2021 | $120K |
| 2022 | $120K |
| 2023 | $120K |
| 2024 | $160K |
| 2025 | $160K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid
- •Work to protect patent protections for pharmaceutical companies and other general issues relating to the Pharmaceutical Industry
- •Work to protect patent protections for pharmaceutical companies and other general issues relating to the Pharmaceutical Industry, Medicare Part B
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
National Community Pharmacists Association
$15.4M total spend
Healthcare Distribution Alliance (Formerly - Hdma)
$13.2M total spend
American Academy of Otolaryngology-head and Neck Surgery
$8.0M total spend
Infectious Diseases Society of America
$5.1M total spend
National Hospice and Palliative Care Organization
$5.0M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.